SEC Filing Details Document Details Form 6-K Filing Date September 01, 2022 Document Date September 01, 2022 Form Description Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Filing Group Current Reports Company VBL Therapeutics Issuer Vascular Biogenics Ltd. Filing Formats View HTML Download PDF Download DOC Download XLS